Compounds > 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Aortic Valve Stenosis

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Aortic Valve Stenosis in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Aortic Valve Stenosis: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yuan, ZS1
Zhou, YZ1
Liao, XB1
Luo, JW1
Shen, KJ1
Hu, YR1
Gu, L1
Li, JM1
Tan, CM1
Chen, HM1
Zhou, XM1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Aortic Valve Stenosis

ArticleYear
Apelin attenuates the osteoblastic differentiation of aortic valve interstitial cells via the ERK and PI3-K/Akt pathways.
    Amino acids, 2015, Volume: 47, Issue:12

    Topics: Adult; Alkaline Phosphatase; Aortic Valve; Aortic Valve Stenosis; Apelin; Calcinosis; Cell Different

2015